A median prostate-specific antigen (PSA) level of 30.7 ng/ml for incident cases of PCa in Jamaica was reported with almost a third of men having a PSA level greater than 100 ng/ml [10]. The gene discussed is KLK3; the disease is posterior cortical atrophy.